Macrogen, Inc. (KOSDAQ:038290)
12,850
+760 (6.29%)
Jun 10, 2026, 3:30 PM KST
Macrogen Market Cap
Macrogen has a market cap or net worth of 139.31 billion as of June 10, 2026. Its market cap has decreased by -18.67% in one year.
Market Cap
139.31B
Enterprise Value
192.26B
Revenue
199.60B
Ranking
n/a
PE Ratio
36.66
Stock Price
12,850.00
Market Cap Chart
Since September 14, 2000, Macrogen's market cap has decreased from 148.29B to 139.31B, a decrease of -6.05%. That is a compound annual growth rate of -0.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 139.31B | -23.83% |
| Dec 30, 2025 | 182.89B | 11.21% |
| Dec 30, 2024 | 164.45B | -21.52% |
| Dec 28, 2023 | 209.56B | 8.16% |
| Dec 29, 2022 | 193.74B | -33.59% |
| Dec 30, 2021 | 291.72B | 9.42% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EASY BIO,Inc. | 209.74B |
| Bioneer | 208.29B |
| JETEMA, | 186.79B |
| Genexine | 151.90B |
| Vaxcell-Bio Therapeutics | 119.08B |
| MedPacto | 118.76B |
| ENCell | 101.32B |
| Amicogen | 99.20B |